
We're Balanced Pharma.
We're improving lives
by improving
patient comfort.
Current Product Pipeline
Target product profiles
BPI-004
BPI-004
Best-in-class post-surgical analgesic
BPI-004 (“Enduracaine”) is a non-opioid, single-dose injectable local analgesic that provides up to three days of pain relief following surgical procedures.
- Non-opioid
- Multi-day pain relief
- Low toxicity
- Low motor impairment
Oral & maxillofacial surgery, orthopedic surgery, general surgery, podiatric surgery, gynecological surgery, CT surgery
View Helping End the Opioid Crisis
View the 40-second video: Helping End the Opioid Crisis

BPI-001
BPI-001
Best-in-class local dental anesthetic
BPI-001 (“Libracaine”) is a best-in-class, injectable anesthetic for dental procedures that is significantly less painful, faster-acting, and more likely to get patients numb than the current drugs.
- Less painful
- Faster-acting
- More reliable
- Same safety profile
- Same shelf-life
- Same cartridge
Traction
$10+ MM raised, including an $8 MM A round, led by the leading strategic in the dental anesthetic space
- Experienced team
- Three successful FDA meetings
- Produced and tested commercial prototypes
- Arranged supply chain
- Arranged manufacturing and distribution
- Four utility patents
- Successful pre-clinical trial
- 150+ doctors have invested in Balanced Pharma
Recent Press

Septodont Invests in Balanced Pharma, Joins Board
Featured in Dentistry Today | January 20, 2025
Septodont, the dominant global leader in dental anesthetics, has made a strategic investment in Balanced Pharma Inc. (“BPI”) as part of an institutional funding round, and Septodont COO Atif Zia has...

Balanced Pharma Analgesic Aims to Lower Opioid Use
Featured in Dentistry Today | November 12, 2024
Balanced Pharma Incorporated (BPI) has announced the acquisition of rights to a promising new non-opioid injectable post-surgical pain relief drug...

Dr. Howard S. Glazer Joins Balanced Pharma
Featured in Conexiant | March 12, 2024
Leading dental educator predicts huge impact for patients, providers. Howard S. Glazer, DDS, FAGD has joined Balanced Pharma’s Scientific Advisory Board. Dr. Glazer, an award-winning, leading voice in dental education...

Balanced Pharma Expands Patent Portfolio for Less Painful Dental Anesthetic
Featured in Conexiant | December 21, 2023
Dentist-founded company receives additional U.S. patent for its dental cartridge technology...

